Team

Suguru Ueno Suguru Ueno

Venture

After graduating from the Graduate School of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences at the University of Tokyo, he was in charge of the proposal of themes for antibody-drug conjugates and non-clinical research at DAIICHI SANKYO's Antibody Research Laboratories and U3Pharma (Germany). After that, as a global project leader in the Oncology Clinical Development Department, he was responsible for planning and promoting the development strategy and confirmed the clinical Proof of Concept. Since 2019, he has been engaged in new allogenic technology research at the Institute of Cell Therapy, and since 2023, he has been engaged in basic research connecting organisms and devices as a visiting researcher of neurophysiology and chemistry research at Stanford University in the United States. He joined JAFCO in April 2025 and is engaged in investment and support for R&D-type startups in the Industry-Academia-Life Science Investment Group of the Venture Investment Division. Doctor of Pharmacy.

I think the important thing is whether I can keep moving forward, no matter how much I get knocked down. Even in the face of difficulties, I believe that if we can stand firm, endure, and keep going step by step, there will always be a way forward.